on Mar 29,2018
QUÉBEC city, March 29, 2018 – CQDM is pleased to announce the selection of a new Quantum Leap project jointly with Feldan Therapeutics for a total amount of $1.2M. The …
Read Storyon Mar 16,2018
Feldan Therapeutics will be attending the Innate Killer Summit from March 27 to 29 in San Diego, CA, USA. Come and meet with our Business Development Director Meriem Benchabane and …
Read Storyon Jan 17,2018
Read the new article on the Feldan Shuttle Technology published in Drug Development & Delivery edition on January 2018. download article : wwwdrug-devcom/Uploads/Public/January%202018%20WEBpdf …
Read Storyon Jan 15,2018
Combined Feldan Shuttle and Green Cross LabCell NK cell technologies will be used to develop hyperactive NK cell immunotherapies QUEBEC, Jan. 15, 2018 /CNW Telbec/ - Green Cross LabCell, involved …
Read Storyon Aug 22,2017
QUEBEC CITY, Aug. 22, 2017 - Feldan Therapeutics, Inc. today announced the issuance of its first patent covering the company's technology, the Feldan Shuttle platform. The United States Patent and …
Read Storyon Apr 30,2017
Feldan Therapeutics will be attending the BIO International Convention 2017 June 19-22, 2017 in San Diego, CA. We are excited to be part in this even again this year! Our …
Read Storyon Sep 30,2016
Feldan Therapeutics and Elasmogen Announce Research Agreement with Amgen to Develop Intracellular Biologics Combined Feldan Shuttle and Elasmogen soloMER technology will be used to deliver intracellular candidates for two targets …
Read Story
2666, Boul. du Parc Technologique, Suite 290
Quebec, Qc, Canada,
G1P 4S6
Phone: 1-418-872-7277
Email: info@feldan.com